Tenser R B, Hay K A, Aberg J A
Division of Neurology, Penn State University College of Medicine, Hershey.
Arch Neurol. 1993 Apr;50(4):417-20. doi: 10.1001/archneur.1993.00540040069017.
Six patients with relapsing chronic progressive multiple sclerosis were treated on 2 consecutive days with large amounts of IgG to induce immunosuppression. Peripheral blood lymphocyte subsets were monitored for 5 weeks after IgG treatment to determine immunosuppression. Decreased numbers of B, T, and natural killer lymphocytes were detected after treatment. Lymphocyte numbers were at a nadir 1 week after treatment, but an immunosuppressive effect continued to be present after 5 weeks. Although clinical efficacy was not evident in this brief open trial, the decrease of peripheral lymphocyte numbers and the apparent safety of the procedure warrant further study.
6例复发型慢性进展性多发性硬化症患者连续2天接受大剂量免疫球蛋白(IgG)治疗以诱导免疫抑制。IgG治疗后5周监测外周血淋巴细胞亚群以确定免疫抑制情况。治疗后检测到B淋巴细胞、T淋巴细胞和自然杀伤淋巴细胞数量减少。淋巴细胞数量在治疗后1周降至最低点,但5周后仍存在免疫抑制作用。尽管在这项简短的开放性试验中临床疗效不明显,但外周淋巴细胞数量的减少以及该治疗方法明显的安全性值得进一步研究。